Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Heerlein, K.
  • De Giorgi, S.
  • Degraeve, G.
  • Frodl, T.
  • Hagedoorn, W.
  • Oliveira-Maia, A. J.
  • Otte, C.
  • Perez Sola, V
  • Rathod, S.
  • Rosso, G.
  • Vita, A.
  • Morrens, J.
  • Rive, B.
  • Mulhern Haughey S
  • Kambarov, Y.
  • Young, A. H.

Grupos

Abstract

Treatment resistant depression (TRD) is diagnosed when patients experiencing a major depressive episode fail to respond to =2 treatments. Along with substantial indirect costs, patients with TRD have higher healthcare resource utilization (HCRU) than other patients with depression. However, research on the economic impact of this HCRU, and differences according to response to treatment, is lacking.

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0165-0327, 1573-2517

JOURNAL OF AFFECTIVE DISORDERS  ELSEVIER

Tipo:
Article
Páginas:
442-450
PubMed:
34742998
Factor de Impacto:
1,791 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 35

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Healthcare resource utilization, Major depressive disorder, Observational study, Real-world evidence, Treatment resistant depression

Campos de Estudio

Compartir